一项新的血液测试预测,在所有澳大利亚人中,糖尿病肾脏疾病提前四年以很高的准确性出现。 A new blood test predicts diabetic kidney disease up to four years early with high accuracy in all Australians.

名为ProprignerD的新血液测试可以预测糖尿病肾病在症状出现前四年内就会出现,土著和非土著澳大利亚人的精确度与此类似。 A new blood test called PromarkerD can predict diabetic kidney disease up to four years before symptoms appear, with similar accuracy in Indigenous and non-Indigenous Australians. 测试使用蛋白质和临床生物标志, 配有评估风险的算法, 提供超过85%的负预测值。 Developed by Perth-based Proteomics International Laboratories, the test uses protein and clinical biomarkers with an algorithm to assess risk, offering over 85% negative predictive value. 该药物现已在全国范围内适用于2型糖尿病患者，可能有助于针对预防护理，尤其是在肾病发病率高出七倍的土著社区。 It’s now available nationwide for type 2 diabetes patients and may help target preventive care, especially in Indigenous communities where kidney disease rates are seven times higher.